ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2026
Hemodialysis Facilities, Vascular Access Surgeons, and Central Venous Catheter Use: A Retrospective Cohort Study.
Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
RATIONALE &
objectiveReducing central venous catheter (CVC) use for hemodialysis among patients with kidney failure receiving maintenance hemodialysis is an important priority. Previous reports have suggested that partnerships between hemodialysis facilities and vascular access surgeons lead to reduced rates of CVC use. We studied whether a greater intensity of these relationships was associated with less use of CVCs. STUDY
designNational retrospective cohort study. SETTING &
participants109,293 patients with kidney failure receiving maintenance hemodialysis within 4,402 facilities. EXPOSURE: Facility-level Herfindahl-Hirschman index (HHI), an established measure of market concentration used as a proxy for closeness of the relationship between hemodialysis facilities and vascular access surgeons, with higher indices suggesting closer relationships. OUTCOME: Greater than 90 days of continuous CVC use for hemodialysis in 2018. ANALYTICAL APPROACH: Mixed-effects logistic regression model including patient-level covariates, facility-level covariates, and facility random effects. Dialysis facilities were divided into quartiles based on increasing HHI. Multiple sensitivity analyses were conducted using similar models.
resultsPatients in facilities in the highest HHI quartile were less likely to have continued catheter use for more than 90 days than those in the lowest quartile (odds ratio, 0.80; 95% confidence interval, 0.75-0.87; P < 0.001). This association was also observed in multiple sensitivity analyses. LIMITATIONS: Misclassification of the exposure, inclusion of patients insured by Medicare Fee-for-Service, unmeasured confounding.
conclusionsMore extensive partnerships between dialysis facilities and vascular access surgeons reflected by the HHI were associated with lower rates of CVC use for hemodialysis. PLAIN-LANGUAGE SUMMARY: The goal of this study was to learn if patients in dialysis facilities that partnered with surgeons (measured using a marker of market concentration) who place and maintain permanent hemodialysis vascular access grafts and fistulas experienced lower use of a temporary form of vascular access for hemodialysis, central venous catheters, which are associated with an increased risk of infection. We found that closer partnerships between hemodialysis centers and surgeons were associated with less use of catheters for the patients served by those dialysis centers. These findings may inform strategies to reduce the use of central venous catheters and improve outcomes for patients with kidney failure requiring dialysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.